Several comprehensive recent articles excellently review the functional basics of signaling pathways in general; and of MAPK-, Stat3-and NFkB-signaling, in particular; as well as the pathophysiologic role of protein kinases and emerging inhibitors in MM [97,98,99]. This evidence concerns the gene STAT3 and Miyoshi myopathy.